Early recurrence after curative resection in oligonodular hepatocellular carcinoma. 2013

Liang Huang, and Jing Li, and Jianjun Yan, and Jie Cao, and Caifeng Liu, and Xianghua Zhang, and Mengchao Wu, and Yiqun Yan
Department of Hepatic Surgery I, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China.

OBJECTIVE Often patients experience an unexpected early recurrence after hepatectomy for multinodular HCC. We conducted this retrospective study to observe the recurrence rate within 1 year after hepatectomy for oligonodular HCC (2 or 3 nodules) and investigate the risk factors for early recurrence. METHODS The study population consisted of 102 patients with 2 or 3 HCCs that received curative resection between January 2009 and December 2009. Clinicopathological data were collected and subjected to univariate and multivariate analysis. RESULTS Forty-three (42.2%) patients were diagnosed as with recurrence within 1 year after hepatectomy. According to univariate analysis, the risk factors for early recurrence were alpha-fetoprotein (AFP) >200 ng/mL, microvascular involvement and lack of complete tumor capsule; microvascular involvement was an independent predictive factor for early recurrence by multivariate analysis (HR, 4.02; 95% CI, 1.42-11.39, p=0.009). CONCLUSIONS There was a high rate of early recurrence for patients with oligonodular HCC (2 or 3 nodules) after hepatectomy. Microvascular involvement was an independent predictive factor for early recurrence, and adjuvant therapy, such as TACE, may be considered for those patients af

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D005260 Female Females
D006498 Hepatectomy Excision of all or part of the liver. (Dorland, 28th ed) Hepatectomies
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Liang Huang, and Jing Li, and Jianjun Yan, and Jie Cao, and Caifeng Liu, and Xianghua Zhang, and Mengchao Wu, and Yiqun Yan
August 2020, The Journal of international medical research,
Liang Huang, and Jing Li, and Jianjun Yan, and Jie Cao, and Caifeng Liu, and Xianghua Zhang, and Mengchao Wu, and Yiqun Yan
October 2015, BMC cancer,
Liang Huang, and Jing Li, and Jianjun Yan, and Jie Cao, and Caifeng Liu, and Xianghua Zhang, and Mengchao Wu, and Yiqun Yan
February 2010, Hepatobiliary & pancreatic diseases international : HBPD INT,
Liang Huang, and Jing Li, and Jianjun Yan, and Jie Cao, and Caifeng Liu, and Xianghua Zhang, and Mengchao Wu, and Yiqun Yan
February 2019, Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract,
Liang Huang, and Jing Li, and Jianjun Yan, and Jie Cao, and Caifeng Liu, and Xianghua Zhang, and Mengchao Wu, and Yiqun Yan
August 2012, Korean journal of hepato-biliary-pancreatic surgery,
Liang Huang, and Jing Li, and Jianjun Yan, and Jie Cao, and Caifeng Liu, and Xianghua Zhang, and Mengchao Wu, and Yiqun Yan
October 2016, World journal of surgery,
Liang Huang, and Jing Li, and Jianjun Yan, and Jie Cao, and Caifeng Liu, and Xianghua Zhang, and Mengchao Wu, and Yiqun Yan
August 2015, Radiology,
Liang Huang, and Jing Li, and Jianjun Yan, and Jie Cao, and Caifeng Liu, and Xianghua Zhang, and Mengchao Wu, and Yiqun Yan
February 2011, Journal of surgical oncology,
Liang Huang, and Jing Li, and Jianjun Yan, and Jie Cao, and Caifeng Liu, and Xianghua Zhang, and Mengchao Wu, and Yiqun Yan
August 2016, Surgery,
Liang Huang, and Jing Li, and Jianjun Yan, and Jie Cao, and Caifeng Liu, and Xianghua Zhang, and Mengchao Wu, and Yiqun Yan
March 1989, Hepatology (Baltimore, Md.),
Copied contents to your clipboard!